CFO
IDXX icon

CVA Family Office’s Idexx Laboratories IDXX Stock Holding History

CVA Family Office’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$145K Buy
275
+4
+1% +$2.24K 0.01% 405
2026
Q1 		$152K Buy
271
+33
+14% +$21.2K 0.02% 371
2025
Q4 		$161K Buy
238
+2
+0.8% +$1.36K 0.02% 331
2025
Q3 		$151K Buy
236
+5
+2% +$3.04K 0.02% 341
2025
Q2 		$124K Sell
231
-15
-6% -$7.17K 0.02% 371
2025
Q1 		$103K Buy
246
+11
+5% +$4.78K 0.02% 385
2024
Q4 		$97.2K Buy
235
+28
+14% +$12.3K 0.02% 398
2024
Q3 		$105K Buy
207
+8
+4% +$3.89K 0.02% 361
2024
Q2 		$97K Buy
199
+3
+2% +$1.51K 0.02% 361
2024
Q1 		$106K Buy
196
+1
+0.5% +$546 0.02% 344
2023
Q4 		$108K Buy
+195
New +$91.5K 0.02% 326
2023
Q3 		– Sell
-200
Closed -$100K – 567
2023
Q2 		$100K Sell
200
-3
-1% -$1.44K 0.02% 311
2023
Q1 		$102K Buy
203
+13
+7% +$6.22K 0.02% 307
2022
Q4 		$77.5K Sell
190
-25
-12% -$9.7K 0.02% 322
2022
Q3 		$70K Buy
215
+135
+169% +$49.6K 0.02% 297
2022
Q2 		$28K Sell
80
-45
-36% -$18.4K 0.01% 471
2022
Q1 		$68K Sell
125
-69
-36% -$36.3K 0.02% 331
2021
Q4 		$128K Buy
+194
New +$122K 0.03% 209
2021
Q3 		– Sell
-194
Closed -$123K – 592
2021
Q2 		$123K Buy
194
+129
+198% +$71.2K 0.04% 211
2021
Q1 		$32K Buy
+65
New +$32.6K 0.01% 332

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

CVA Family Office's IDXX Position: Q2 2026 in Review

CVA Family Office increased its Idexx Laboratories (IDXX) stake by 1.5% in Q2 2026, buying an estimated $2.24K and bringing the position to 275 shares worth $145K. The position accounts for 0.01% of the portfolio, ranked #405.

CVA Family Office first reported a position in IDXX in Q1 2021 and has held it in 20 quarters since. The position peaked at $161K in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • CVA Family Office held 275 shares of Idexx Laboratories worth $145K as of Q2 2026.
  • CVA Family Office bought 4 Idexx Laboratories shares in Q2 2026, an estimated $2.24K.
  • Idexx Laboratories made up 0.01% of CVA Family Office's portfolio in Q2 2026, its #405 holding.
  • CVA Family Office first reported a position in Idexx Laboratories in Q1 2021 and has held it in 20 quarters since.
  • CVA Family Office's Idexx Laboratories position peaked at $161K in Q4 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.